The IgG λ light chain is a vital component of the immune system's arsenal, playing a key role in the function of IgG antibodies. These antibodies are pivotal for the adaptive immune response, offering specificity in the recognition and neutralization of pathogens such as bacteria and viruses. The λ light chain pairs with the heavy chain of the antibody to form a specific antigen-binding site. The diversity and specificity of the light chains are crucial for the vast repertoire of antibodies that an individual can produce. The regulation of IgG λ light chain expression is a complex process, involving a network of cellular signals that ensure an appropriate immune response is mounted when required. The expression of this light chain is not static and can be upregulated in response to various stimuli, typically as part of the body's defense mechanism.
A range of chemical compounds, not including peptides, proteins, or antibodies, have been identified as potential activators that could induce the expression of the IgG λ light chain. These activators operate through diverse mechanisms, such as direct stimulation of B cells, imitation of pathogenic components to elicit an immune response, or modulation of signaling pathways that govern immune cell development and function. For instance, compounds like lipopolysaccharide mimic the presence of a bacterial infection, promoting an immune response that includes the upregulation of IgG λ light chain expression. Similarly, synthetic compounds like CpG oligodeoxynucleotides can stimulate the immune system by mimicking bacterial DNA, thereby potentially increasing the production of IgG antibodies. Other activators may interact with cellular pathways that are indirectly involved in immune regulation, such as the sirtuin pathways influenced by resveratrol, which can result in heightened immune cell activity and possibly enhance λ light chain production. Understanding the diverse mechanisms through which these activators operate provides insight into the intricate regulation of antibody production and the adaptive immune response.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lipopolysaccharide, E. coli O55:B5 | 93572-42-0 | sc-221855 sc-221855A sc-221855B sc-221855C | 10 mg 25 mg 100 mg 500 mg | $98.00 $171.00 $425.00 $1560.00 | 12 | |
Lipopolysaccharide might trigger an immune cascade that specifically upregulates IgG λ light chain production as part of the body's defense against Gram-negative bacterial infection. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA could directly stimulate the expression of IgG λ light chain by mimicking diacylglycerol, leading to the activation of protein kinase C and subsequent B cell activation. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid might induce the production of IgG λ light chain by enhancing the germinal center reaction where B cell differentiation occurs. | ||||||
Concanavalin A | 11028-71-0 | sc-203007 sc-203007A sc-203007B | 50 mg 250 mg 1 g | $119.00 $364.00 $947.00 | 17 | |
Concanavalin A may increase the expression of IgG λ light chain through robust stimulation of B cell proliferation and subsequent differentiation into antibody-secreting cells. | ||||||
Imiquimod | 99011-02-6 | sc-200385 sc-200385A | 100 mg 500 mg | $67.00 $284.00 | 6 | |
Imiquimod could directly induce expression of IgG λ light chain by engaging toll-like receptor 7 (TLR7), which promotes an innate immune response and can lead to adaptive immune responses including antibody production. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol may upregulate IgG λ light chain expression by activating sirtuin pathways, which are involved in the regulation of lifespan and metabolism in immune cells. | ||||||
Fingolimod | 162359-55-9 | sc-507334 | 10 mg | $160.00 | ||
Fingolimod could stimulate the expression of IgG λ light chain by sequestering lymphocytes in lymph nodes, inadvertently promoting interactions that lead to B cell activation. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
By inhibiting proteasome function, bortezomib may increase the expression of IgG λ light chain due to the accumulation of regulatory proteins that govern B cell development and function. | ||||||